European Heart Journal Advance Access published online on February 25, 2005
European Heart Journal, doi:10.1093/eurheartj/ehi167
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 The Mayo Clinic and Mayo Foundation, Rochester, MN, USA
* To whom correspondence should be addressed. Aims ST-segment recovery (
Clinical research
Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction
2 Columbia University Medical Centre and the Cardiovascular Research Foundation, 55E. 59th St, 6th floor, New York City, NY 10022, USA
3 Beth Israel Deaconess Medical Centre, Boston, MA, USA
4 Mid Carolina Cardiology, Charlotte, NC, USA
5 Hospital Gregorio Marañón, Madrid, Spain
6 Duke University Medical Centre, Durham, NC, USA
7 William Beaumont Hospital, NY, USA
Gregg W. Stone, E-mail: gstone{at}crf.org
![]()
Abstract
STR) and myocardial blush (MB) evaluate different elements of microcirculatory integrity after reperfusion therapy in acute myocardial infarction (AMI). We sought to determine whether the combination of
STR and MB after primary percutaneous coronary intervention (PCI) in AMI has greater prognostic utility than either measure alone.Methods and results The 30 days and 1 year clinical outcomes of 456 patients were assessed as a function of
STR and MB after primary PCI from the CADILLAC trial.
STR and MB were concordant (
70%
STR and MB grade 2/3 or <70%
STR and MB grade 0/1) in 60.1% of patients and discordant in 39.9% of patients. The greatest survival was observed among patients with complete
STR (
70%) and MB grade 2/3 in whom the cumulative rates of death at 30 days and 1 year were 0.6 and 1.2%, respectively. Poorest survival was observed among patients with incomplete
STR (<70%) and reduced MB (grade 0/1), in whom 30 days and 1 year rates of death were 8.3 and 10.1%, respectively. Intermediate outcomes were present in patients with discordant MB and
STR. By multivariable analysis, however,
STR was an independent correlate of survival at 30 days and 1 year (P = 0.05 and 0.01, respectively), whereas MB was no longer predictive (P = 0.38 and 0.72, respectively).Conclusion
STR and MB are not infrequently discordant after primary PCI. By univariate analysis, both measures of reperfusion success strongly correlate with survival and assessment of both yields incremental prognostic information beyond either measure alone. By multivariable analysis, however,
STR is the stronger prognostic variable.![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. Nijveldt, P. A. van der Vleuten, A. Hirsch, A. M. Beek, R. A. Tio, J. G.P. Tijssen, J. J. Piek, A. C. van Rossum, and F. Zijlstra Early Electrocardiographic Findings and MR Imaging-Verified Microvascular Injury and Myocardial Infarct Size J. Am. Coll. Cardiol. Img., October 1, 2009; 2(10): 1187 - 1194. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Niccoli, F. Burzotta, L. Galiuto, and F. Crea Myocardial no-reflow in humans. J. Am. Coll. Cardiol., July 21, 2009; 54(4): 281 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, F. Van de Werf, J. Bax, A. Betriu, C. Blomstrom-Lundqvist, F. Crea, V. Falk, G. Filippatos, K. Fox, K. Huber, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology: Eur. Heart J., December 1, 2008; 29(23): 2909 - 2945. [Full Text] [PDF] |
||||
![]() |
R. Nijveldt, A. M. Beek, A. Hirsch, M. G. Stoel, M. B.M. Hofman, V. A.W.M. Umans, P. R. Algra, J. W.R. Twisk, and A. C. van Rossum Functional recovery after acute myocardial infarction comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. J. Am. Coll. Cardiol., July 15, 2008; 52(3): 181 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Porto, L. Testa, and A. P. Banning Plaque Burden, Intravascular Ultrasound, and Distal Embolization Phenomenon J. Am. Coll. Cardiol., April 1, 2008; 51(13): 1323 - 1324. [Full Text] [PDF] |
||||
![]() |
L. Galiuto, B. Garramone, A. Scara, A. G. Rebuzzi, F. Crea, G. La Torre, S. Funaro, M. Madonna, F. Fedele, L. Agati, et al. The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling: results of the multicenter AMICI study. J. Am. Coll. Cardiol., February 5, 2008; 51(5): 552 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Terkelsen and H. R. Andersen Value of ST-resolution analysis in the era of primary percutaneous coronary intervention Heart, January 1, 2008; 94(1): 13 - 15. [Full Text] [PDF] |
||||
![]() |
P. Silva-Orrego, P. Colombo, and R. Bigi Reply J. Am. Coll. Cardiol., April 10, 2007; 49(14): 1586 - 1587. [Full Text] [PDF] |
||||
![]() |
A. Lerman, D. R. Holmes, J. Herrmann, and B. J. Gersh Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both? Eur. Heart J., April 1, 2007; 28(7): 788 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
L De Luca, G Sardella, C J Davidson, G De Persio, M Beraldi, T Tommasone, M Mancone, B L Nguyen, L Agati, M Gheorghiade, et al. Impact of intracoronary aspiration thrombectomy during primary angioplasty on left ventricular remodelling in patients with anterior ST elevation myocardial infarction Heart, July 1, 2006; 92(7): 951 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Terkelsen, B. L. Norgaard, J. F. Lassen, S. H. Poulsen, J. C. Gerdes, E. Sloth, L. B.-H. Gotzsche, F. K. Romer, L. Thuesen, T. T. Nielsen, et al. Potential significance of spontaneous and interventional ST-changes in patients transferred for primary percutaneous coronary intervention: observations from the ST-MONitoring in Acute Myocardial Infarction study (The MONAMI study) Eur. Heart J., February 1, 2006; 27(3): 267 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Valgimigli Tirofiban Plus Sirolimus-Eluting Stent vs Abciximab Plus Bare-Metal Stent--Reply JAMA, October 5, 2005; 294(13): 1617 - 1618. [Full Text] [PDF] |
||||
![]() |
S. Agewall How should we evaluate an open artery in STEMI patients? Eur. Heart J., April 1, 2005; 26(7): 634 - 636. [Full Text] [PDF] |
||||




